Patent details

Basic Information

Publication number:

EP1223918

PCT Application Number:

PCT/GB/00/03014

Type:

European Patent Granted for LU

Legal Status:

Expired

Application number:

EP009532839

PCT Publication Number:

WO/01/05466

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PHARMACEUTICAL COMPOSITIONS COMPRISING A HMG COA REDUCTASE INHIBITOR

French Title of Invention:

COMPOSITIONS PHARMACEUTIQUES RENFERMANT UN INHIBITEUR DE LA HMG REDUCTASE

German Title of Invention:

PHARMAZEUTISCHE ZUSAMMENSETZUNGEN ENTHALTEND EIN HMG-COA REDUCTASE INHIBITOR

SPC Number:

Dates

Filing date:

04/08/2000

Grant date:

05/02/2003

EP Publication Date:

05/02/2003

PCT Publication Date:

02/08/2001

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

24/07/2002

EP B1 Publication Date:

05/02/2003

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

04/08/2020

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

04/08/2000

 

 

Name:

AstraZeneca AB

Address:

-, 151 85 Södertälje, Sweden (SE)

Agent

Name:

ARONOVA S.A.

From:

29/04/2003

Address:

PO Box 327, L-4004, ESCH-SUR-ALZETTE, Luxembourg (LU)

To:

Inventor

1

Name:

CREEKMORE Joseph, Richard

Address:

United States (US)

2

Name:

WIGGINS Norman, Alfred

Address:

United States (US)

Priority

Priority Number:

0001621

Priority Date:

26/01/2000

Priority Country:

United Kingdom (GB)

Classification

Main IPC Class:

A61K 9/20;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

24/07/2019

Last Annual Fee Paid Number:

20

Last Annual Fee Paid Amount:

300 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages